BOSTON, MA—Patients with significant symptomatic degenerative mitral regurgitation (MR) who had complex anatomy making them ineligible for inclusion in the CLASP IID trial can be treated safely and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback